Approval · Notice of Compliance 28198 · 2022
DIGOXIN INJECTION C.S.D.: Notice of Compliance 28198
Issued May 16, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 28198
- Date
- May 16, 2022
- Company
- Sandoz Canada Inc.Saint-Hubert, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Replacement of a drug substance manufacturing site and manufacturer. Change in the specification for the drug product tests and acceptance criteria. Change in the specification for the drug product
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DIGOXIN INJECTION C.S.D. | Not yet assigned | — |
Medicinal ingredients
- DIGOXIN 0.5 MG per 2ML